Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Comparison of the effects of mirtazapine and fluoxetine in severely depressed patients.

Versiani M, Moreno R, Ramakers-van Moorsel CJ, Schutte AJ; Comparative Efficacy Antidepressants Study Group.

CNS Drugs. 2005;19(2):137-46.

PMID:
15697327
2.

Mirtazapine versus selective serotonin reuptake inhibitors.

Thompson C.

J Clin Psychiatry. 1999;60 Suppl 17:18-22; discussion 46-8. Review.

4.

Clinical efficacy of mirtazapine: a review of meta-analyses of pooled data.

Kasper S.

Int Clin Psychopharmacol. 1995 Dec;10 Suppl 4:25-35. Review. Erratum in: Int Clin Psychopharmacol 1996 Jun;11(2):153.

PMID:
8930007
5.

[Use of antidepressant drugs in schizophrenic patients with depression].

Micallef J, Fakra E, Blin O.

Encephale. 2006 Mar-Apr;32(2 Pt 1):263-9. Review. French.

PMID:
16910628
6.

Care of depressed patients with anxiety symptoms.

Nutt DJ.

J Clin Psychiatry. 1999;60 Suppl 17:23-7; discussion 46-8. Review.

7.

Mirtazapine, an antidepressant.

Puzantian T.

Am J Health Syst Pharm. 1998 Jan 1;55(1):44-9. Review.

PMID:
9437474
8.

A risk-benefit assessment of mirtazapine in the treatment of depression.

Kasper S, Praschak-Rieder N, Tauscher J, Wolf R.

Drug Saf. 1997 Oct;17(4):251-64. Review. Erratum in: Drug Saf 1998 Feb;18(2):123.

PMID:
9352961
9.

Mirtazapine. A pharmacoeconomic review of its use in depression.

Holm KJ, Jarvis B, Foster RH.

Pharmacoeconomics. 2000 May;17(5):515-34. Review.

PMID:
10977391
10.
11.

Mirtazapine: a review of its use in major depression.

Holm KJ, Markham A.

Drugs. 1999 Apr;57(4):607-31. Review.

PMID:
10235695
12.

Mirtazapine: clinical advantages in the treatment of depression.

Burrows GD, Kremer CM.

J Clin Psychopharmacol. 1997 Apr;17 Suppl 1:34S-39S. Review.

PMID:
9090576
13.

Efficacy of antidepressants in the treatment of severe depression: the place of mirtazapine.

Kasper S.

J Clin Psychopharmacol. 1997 Apr;17 Suppl 1:19S-28S. Review.

PMID:
9090574
14.

Safety of mirtazapine: a review.

Montgomery SA.

Int Clin Psychopharmacol. 1995 Dec;10 Suppl 4:37-45. Review. Erratum in: Int Clin Psychopharmacol 1996 Jun;11(2):153.

PMID:
8930008
15.

New developments in the treatment of depression.

Montgomery SA.

J Clin Psychiatry. 1999;60 Suppl 14:10-5; discussion 31-5. Review.

16.

Fluoxetine tenth anniversary update: the progress continues.

Stokes PE, Holtz A.

Clin Ther. 1997 Sep-Oct;19(5):1135-250. Review.

PMID:
9385500
17.

[Therapeutic action lag time and resistance to treatment].

Peretti CS.

Encephale. 1999 Jun;25 Spec No 2:49-54. Review. French.

PMID:
10434159
18.

Spotlight on sertraline in the management of major depressive disorder in elderly patients.

Muijsers RB, Plosker GL, Noble S.

CNS Drugs. 2002;16(11):789-94. Review.

PMID:
12383038
19.

Sertraline: a review of its use in the management of major depressive disorder in elderly patients.

Muijsers RB, Plosker GL, Noble S.

Drugs Aging. 2002;19(5):377-92. Review.

PMID:
12093324
20.

An overview of the clinical efficacy of mirtazapine.

Benkert O, Muller M, Szegedi A.

Hum Psychopharmacol. 2002 Jun;17 Suppl 1:S23-6. Review.

PMID:
12404666

Supplemental Content

Support Center